Fueled by Roivant Deal, Sumitomo Dainippon Accelerating DX as It Looks Beyond Latuda LOE

July 9, 2021
Sumitomo Dainippon Pharma is speeding up its digital transformation (DX) by leveraging a technology platform it acquired through its strategic alliance with Roivant Sciences. With the application of the platform making steady headway in the US for drug discovery and...read more